DF1001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DF1001, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Study of DF1001 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]